Calling for EASL Emerging Leader Award & EASL Nurses & AHPs Rising Star candidates
The EASL Congress 2023 is around the corner, and we are looking for our next awardees to celebrate.
Joint EASL, AASLD and ILTS survey on world practice and barriers to the utilization of HBsAg-positive organs in adult recipients
In a joint effort, EASL, together with the International Liver Transplantation Society (ILTS) and the American Association for the Study of Liver Diseases (AASLD), is launching a survey aimed at transplant centres worldwide on the utilization of HbsAg-positive organs in…
Call for Applications for Position of Editor-in-Chief, JHEP Reports
About JHEP Reports Published since 2019, JHEP Reports is EASL’s first open access journal with a 2021 Impact Factor of 9.917. JHEP Reports is an innovative Journal publishing articles on global issues in hepatology, with specific focus on clinical trials,…
Bringing Care to All European Patients: EASL Advocacy Events for Liver Cancer Awareness Month
This October 2022, in honour of Liver Cancer Awareness Month, EASL participated in organising two important advocacy events aimed at identifying and implementing strategies to enhance awareness of liver cancer and engage key policymakers at the EU level.
Liver cancer cases and deaths projected to rise by more than 55% by 2040
Amsterdam, October 6, 2022 – A new analysis reveals that primary liver cancer was among the top three causes of cancer death in 46 countries in 2020 and the number of people diagnosed with or dying from primary liver cancer…
United Action for Better Health in Europe
On 12-14 September 2022, representatives from civil society, partnering organizations, and the 53 Member States of the WHO European Region met in Tel Aviv, Israel for the 72nd governance session. The session was designed to assess progress and establish next…
Living donor transplantation offers a safe alternative for liver transplant patients
Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for increasing the use of living donor liver transplantation (LDLT)…
Introducing the new EASL Membership structure
From the very beginning, EASL’s mission has been to be the “Home of Hepatology”. Providing education to everyone interested in hepatology and engaging with all stakeholders in the liver field wherever they are based. Through its 66 years of existence,…
Treatment in Pregnancy for Hepatitis C (TiP-HepC) Clinical Case Registry
Although DAA medications have demonstrated excellent safety and efficacy in non-pregnant individuals, they are not currently approved for HCV treatment in pregnant women due to a lack of safety data. Clinical trials assessing the safety of DAAs in pregnancy and…
Instagram Contest: Join the MOVEment!
Follow us @easl.news on Instagram Like the contest post Comment under the post how you are joining the MOVEment against NAFLD Post a Story showing how you fight NAFLD by tagging us @easl.news + using #nafldsummit Entries will on 14…